[AAAS] T cell–mediated depletion of intratumoral regulatory T cells using a CCR8xCD3 T cell–engaging bispecific antibody (TCB) promotes antitumor immunity in preclinical mouse models

ege2023usa Post time 10 hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-11-04 04:23

Reward10points

Edited by ege2023usa at 2026-11-1 04:24

journal：Science Translational Medicine

Authors：Baomei Wang; Isabel Ishizuka; Emel Esen; Ji Li; Cecilia Chiu; Yonglian Sun; Zhonghua Lin; Dhaya Seshasayee; Aija Kusi; Yu Zhong; Wendy Halpern; Adeyemi O. Adedeji; Lanlan Yu; Peter Tran; Zhaojun Yin; Shang-Fan Yu; Geoff Del Rosario; Yoko Oei; Yagai Yang; Jill Schartner; Mary Ann Go; Giulia Protti; Soren Muller; Cong Wu; Ran Li; Genee Lee; James T. Koerber; Sascha Rutz; Teemu T. Junttila

Published date：2026-10-28

DOI：10.1126/scitranslmed.aea7127

PDF link：https://www.science.org/doi/pdf/10.1126/scitranslmed.aea7127

Article link：https://doi.org/10.1126/scitranslmed.aea7127

Article Source：American Association for the Advancement of Science (AAAS)。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

ege2023usa Lv.3

Intermediate member

post
reply
points
350

[AAAS] T cell–mediated depletion of intratumoral regulatory T cells using a CCR8xCD3 T cell–engaging bispecific antibody (TCB) promotes antitumor immunity in preclinical mouse models

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AAAS] T cell–mediated depletion of intratumoral regulatory T cells using a CCR8xCD3 T cell–engaging bispecific antibody (TCB) promotes antitumor immunity in preclinical mouse models Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AAAS] T cell–mediated depletion of intratumoral regulatory T cells using a CCR8xCD3 T cell–engaging bispecific antibody (TCB) promotes antitumor immunity in preclinical mouse models